Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Arterial dilatation and venous constriction induced by serotonin in the elderly.

Literature DB >> 3240731

Arterial dilatation and venous constriction induced by serotonin in the elderly.

G J Blauw¹, P van Brummelen, P C Chang, P Vermeij, P A van Zwieten.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Serotonin

Year: 1988 PMID： 3240731 DOI： 10.2165/00003495-198800361-00012

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

× No keyword cloud information.

10 in total

1. The acute antihypertensive effect of ketanserin increases with age.

Authors: J De Crée; M Hoing; M De Ryck; J Symoens
Journal: J Cardiovasc Pharmacol Date: 1985 Impact factor: 3.105

2. Detection of deep vein thrombosis with an automatic electrically calibrated strain gauge plethysmograph.

Authors: R W Barnes; D E Hokanson; K K Wu; J C Hoak
Journal: Surgery Date: 1977-08 Impact factor: 3.982

3. Vascular contraction: effect of age and extracellular calcium.

Authors: M L Cohen; B A Berkowitz
Journal: Blood Vessels Date: 1976

4. A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearm.

Authors: P C Chang; R Verlinde; T Bruning; P van Brummelen
Journal: Comput Biol Med Date: 1988 Impact factor: 4.589

5. Age-related changes in vascular responsiveness to cyclic nucleotides and contractile agonists.

Authors: M L Cohen; B A Berkowitz
Journal: J Pharmacol Exp Ther Date: 1974-10 Impact factor: 4.030

6. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.

Authors: M Frenken; A J Kaumann
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1987-04 Impact factor: 3.000

7. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors: J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal: Mol Pharmacol Date: 1985-06 Impact factor: 4.436

8. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors: J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal: J Pharmacol Exp Ther Date: 1981-07 Impact factor: 4.030

9. 5HT3 receptor-mediated vasodilation in the human forearm.

Authors: G J Blauw; P van Brummelen; P C Chang; P Vermeij; P A van Zwieten
Journal: J Hypertens Suppl Date: 1988-12

10. Regional vascular effects of serotonin and ketanserin in young, healthy subjects.

Authors: G J Blauw; P van Brummelen; P C Chang; P Vermeij; P A van Zwieten
Journal: Hypertension Date: 1988-03 Impact factor: 10.190

10 in total

5 in total

Arterial dilatation and venous constriction induced by serotonin in the elderly.

1. The acute antihypertensive effect of ketanserin increases with age.

2. Detection of deep vein thrombosis with an automatic electrically calibrated strain gauge plethysmograph.

3. Vascular contraction: effect of age and extracellular calcium.

4. A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearm.

5. Age-related changes in vascular responsiveness to cyclic nucleotides and contractile agonists.

6. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.

7. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

8. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

9. 5HT3 receptor-mediated vasodilation in the human forearm.

10. Regional vascular effects of serotonin and ketanserin in young, healthy subjects.

Review 1. The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.

Review 2. Age-related changes in vascular smooth muscle and endothelium.

Review 3. Pharmacology of antihypertensive agents with multiple actions.

Review 4. The role of serotonin in cardiovascular diseases and their treatment.

Review 5. Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.